glutathione and diabetic neuropathy D3T acts as a pro-oxidant in a cell culture model of diabetes-induced peripheral IV Glutathione and Diabetes Mellitus

Putative pro-cognitive molecules shift the pattern of both low and high frequency waveforms toward normal patterns indicating improvements in synaptic function

The Promising Findings GHK-Cu has the most robust human evidence, particularly for topical skincare applications BPC-157 shows impressive results in animal studies for wound healing, collagen production, and tissue repair Peptides generally have favorable safety profiles in the studies that exist The mechanisms make biological sense: peptides do play real roles in healing The Limitations Most studies on BPC-157 and TB-500 are animal-based, not human There are no standardized dosing protocols for most injectable peptides Long-term safety data in humans is limited Many peptides are not FDA-approved for cosmetic or surgical recovery purposes Quality control varies widely between compounding pharmacies Important: Many injectable peptides are classified as research compounds and are not approved for human use outside of clinical trials

Readers who were waiting on pharmacy access before sourcing BPC-157 or TB-500 now face an open-ended timeline and the research-use-only market is the same market it was before the documents dropped

In a report published Wednesday in the New England Journal of Medicine, researchers with Pfizer and the University of Texas Medical Branch created a version of the virus that carried the same mutations found in the South African variant dubbed B.1.35.1

Its sensitivity and specificity for diagnosing PD reached 95 and 91%, respectively

Zimmerman RS, Brennan MD, McConahey WM, et al